Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
BMC Health Serv Res
2019 Dec 18;19(1):972.
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 2Z4, Canada.
School of Public Health, University of Alberta, Edmonton, AB, T6G 2E1, Canada.
In the original publication of this article , there is a mistake in the Fig. 2a, 2b, and 2c.